Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson, R Bhargav… - Thrombosis research, 2020 - Elsevier
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
[引用][C] Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson… - Thrombosis …, 2020 - cir.nii.ac.jp
Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson… - Thrombosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
[HTML][HTML] Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson… - Thrombosis …, 2020 - ncbi.nlm.nih.gov
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson, R Bhargav… - 2020 - jdc.jefferson.edu
BACKGROUND: There is no current standardized approach to anticoagulation in patients
with Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
with Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Anticoagulation and bleeding risk in patients with COVID-19.
N Musoke, KB Lo, J Albano, E Peterson… - Thrombosis …, 2020 - europepmc.org
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson… - Thrombosis …, 2020 - thrombosisresearch.com
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
[PDF][PDF] Let us know how access to this document benefits yo u
N Musoke, KB Lo, J Albano, E Peterson, R Bhargav… - core.ac.uk
Background: There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Anticoagulation and bleeding risk in patients with COVID-19.
N Musoke, KB Lo, J Albano, E Peterson, R Bhargav… - 2020 - cabidigitallibrary.org
Background: There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Anticoagulation and bleeding risk in patients with COVID-19.
N Musoke, KB Lo, J Albano, E Peterson… - Thrombosis …, 2020 - europepmc.org
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …